Desidustat

Zydus announces phase-IV Dream-CKD trial to generate real-world evidence of Desidustat in patients with CKD-induced anaemia

Read more

Zydus receives DCGI approval for Oxemia to treat anaemia in CKD patients

Read more

Zydus Cadila Desidustat’s better positioned to get first-to-market advantage within HIF-PHI class in India, says GlobalData

Read more

Zydus develops new treatment for patients suffering from Chronic Kidney Disease (CKD)

Read more

Zydus’ Desidustat efficacious in treating hypoxia in Mexico’s hospitalised COVID-19 patients: Study

Read more

Zydus Cadila gets US FDA nod for drug trials to treat chemotherapy-induced anemia

Read more

Zydus gets nod from COFEPRIS, Mexico to study Desidustat for COVID-19 management

Read more